4
Changes in Ownership
TherapeuticsMD, Inc. Filed Acc 0001387131-18-005451
CEO sold 184,000 shares at an average $5.55 ($1,020,832)
- CEO acquired 184,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finizio Robert G CEO | 2018-10-11 | Option exercise | +92,000 | $0.10 | $9,366 | 18,485,559 | D: show line 1 in the form |
| Finizio Robert G CEO | 2018-10-11 | Sale | −92,000 | $5.65 | $519,616 | 18,393,559 | D: show line 2 in the form |
| Finizio Robert G CEO | 2018-10-12 | Option exercise | +92,000 | $0.10 | $9,366 | 18,485,559 | D: show line 3 in the form |
| Finizio Robert G CEO | 2018-10-12 | Sale | −92,000 | $5.45 | $501,216 | 18,393,559 | D: show line 4 in the form |
| Open-market sales · 184,000 sh · avg $5.55 · $1,020,832 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Finizio Robert G CEO | 2018-10-11 | Option exercise · Non-Qualified Stock Option (right to buy) | −92,000 | 1,012,910 | D: show line 5 in the form | |||||
| Finizio Robert G CEO | 2018-10-12 | Option exercise · Non-Qualified Stock Option (right to buy) | −92,000 | 920,910 | D: show line 6 in the form |
Loading xslF345X03/finizio-form4_101118.xml…